Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF DOSTARLIMAB (TSR-042) PLUS CARBOPLATIN-PACLITAXEL VERSUS PLACEBO PLUS CARBOPLATIN-PACLITAXEL IN PATIENTS WITH RECURRENT OR PRIMARY ADVANCED ENDOMETRIAL CANCER (RUBY) (4010-03-001 / ENGOT EN-6 / GOG-3031)

  • Details

ClinicalTrials.gov ID: NCT03981796
Diagnosis Type: NA
USOR Number: 19034

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, Arizona 85258
55.54 mi. away
P: (480) 993-2950

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: NA
USOR Number: 19046

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, Arizona 85258
55.54 mi. away
P: (480) 993-2950

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Phoenix

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF DOSTARLIMAB (TSR-042) PLUS CARBOPLATIN-PACLITAXEL VERSUS PLACEBO PLUS CARBOPLATIN-PACLITAXEL IN PATIENTS WITH RECURRENT OR PRIMARY ADVANCED ENDOMETRIAL CANCER (RUBY) (4010-03-001 / ENGOT EN-6 / GOG-3031)

  • Details

ClinicalTrials.gov ID: NCT03981796
Diagnosis Type: NA
USOR Number: 19034

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, Arizona 85016
65.69 mi. away
P: (602) 277-4868

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Phoenix

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: NA
USOR Number: 19046

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, Arizona 85016
65.69 mi. away
P: (602) 277-4868

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tempe

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF DOSTARLIMAB (TSR-042) PLUS CARBOPLATIN-PACLITAXEL VERSUS PLACEBO PLUS CARBOPLATIN-PACLITAXEL IN PATIENTS WITH RECURRENT OR PRIMARY ADVANCED ENDOMETRIAL CANCER (RUBY) (4010-03-001 / ENGOT EN-6 / GOG-3031)

  • Details

ClinicalTrials.gov ID: NCT03981796
Diagnosis Type: NA
USOR Number: 19034

  • Practice Details

7695 South Research Dr
Tempe, Arizona 85284
66.80 mi. away
P: (888) 972-2873

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tempe

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: NA
USOR Number: 19046

  • Practice Details

7695 South Research Dr
Tempe, Arizona 85284
66.80 mi. away
P: (888) 972-2873

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, Arizona 85704
119.32 mi. away
P: (520) 531-8967

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF DOSTARLIMAB (TSR-042) PLUS CARBOPLATIN-PACLITAXEL VERSUS PLACEBO PLUS CARBOPLATIN-PACLITAXEL IN PATIENTS WITH RECURRENT OR PRIMARY ADVANCED ENDOMETRIAL CANCER (RUBY) (4010-03-001 / ENGOT EN-6 / GOG-3031)

  • Details

ClinicalTrials.gov ID: NCT03981796
Diagnosis Type: NA
USOR Number: 19034

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, Arizona 85704
119.32 mi. away
P: (520) 531-8967

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: NA
USOR Number: 19046

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, Arizona 85704
119.32 mi. away
P: (520) 531-8967

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma (LEAP-001)(MK-7902-001-00)

  • Details

ClinicalTrials.gov ID: NCT03884101
Diagnosis Type: NA
USOR Number: 18143

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, Arizona 85704
119.32 mi. away
P: (520) 531-8967

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, Arizona 85704
119.74 mi. away
P: (520) 797-4468

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF DOSTARLIMAB (TSR-042) PLUS CARBOPLATIN-PACLITAXEL VERSUS PLACEBO PLUS CARBOPLATIN-PACLITAXEL IN PATIENTS WITH RECURRENT OR PRIMARY ADVANCED ENDOMETRIAL CANCER (RUBY) (4010-03-001 / ENGOT EN-6 / GOG-3031)

  • Details

ClinicalTrials.gov ID: NCT03981796
Diagnosis Type: NA
USOR Number: 19034

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, Arizona 85704
119.74 mi. away
P: (520) 797-4468

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: NA
USOR Number: 19046

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, Arizona 85704
119.74 mi. away
P: (520) 797-4468

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma (LEAP-001)(MK-7902-001-00)

  • Details

ClinicalTrials.gov ID: NCT03884101
Diagnosis Type: NA
USOR Number: 18143

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, Arizona 85704
119.74 mi. away
P: (520) 797-4468

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, Arizona 85711
126.35 mi. away
P: (520) 886-0206

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A PHASE 1/1B MULTICENTER STUDY TO EVALUATE THE HUMANIZED ANTI-CD73 ANTIBODY, CPI-006, AS A SINGLE AGENT OR IN COMBINATION WITH CIFORADENANT, WITH PEMBROLIZUMAB, AND WITH CIFORADENANT PLUS PEMBROLIZUMAB IN ADULT SUBJECTS WITH ADVANCED CANCERS (CPI-006-001)

  • Details

ClinicalTrials.gov ID: NCT03454451
Diagnosis Type: NA
USOR Number: 19082

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, Arizona 85711
126.35 mi. away
P: (520) 886-0206

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF DOSTARLIMAB (TSR-042) PLUS CARBOPLATIN-PACLITAXEL VERSUS PLACEBO PLUS CARBOPLATIN-PACLITAXEL IN PATIENTS WITH RECURRENT OR PRIMARY ADVANCED ENDOMETRIAL CANCER (RUBY) (4010-03-001 / ENGOT EN-6 / GOG-3031)

  • Details

ClinicalTrials.gov ID: NCT03981796
Diagnosis Type: NA
USOR Number: 19034

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, Arizona 85711
126.35 mi. away
P: (520) 886-0206

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: NA
USOR Number: 19046

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, Arizona 85711
126.35 mi. away
P: (520) 886-0206

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma (LEAP-001)(MK-7902-001-00)

  • Details

ClinicalTrials.gov ID: NCT03884101
Diagnosis Type: NA
USOR Number: 18143

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, Arizona 85711
126.35 mi. away
P: (520) 886-0206

More Details View Practice Page